AVDL
Avadel Pharmaceuticals
AVDL
AVDL
52 hedge funds and large institutions have $299M invested in Avadel Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
52
Holders Change
+17
Holders Change %
+48.57%
% of All Funds
1.5%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.12%
New
23
Increased
15
Reduced
7
Closed
6
Calls
$925K
Puts
$825K
Net Calls
+$100K
Net Calls Change
+$92K
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$20.3M |
| 2 |
2
Jennison Associates
New York
|
$20.1M |
| 3 |
BC
3
Broadfin Capital
New York
|
$70.6M |
| 4 |
4
Millennium Management
New York
|
$16.9M |
| 5 |
CCM
5
Consonance Capital Management
New York
|
$14M |
